Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Genomic landscape of susceptibility to severe Covid-19 in the Slovenian population
Authors:ID Kovanda, Anja (Author)
ID Lukežič, Tadeja (Author)
ID Maver, Aleš (Author)
ID Vokač Križaj, Hana (Author)
ID Čižek-Sajko, Mojca (Author)
ID Šelb, Julij (Author)
ID Rijavec, Matija (Author)
ID Bitežnik, Barbara (Author)
ID Rituper, Boštjan (Author)
ID Korošec, Peter (Author)
ID Peterlin, Borut (Author)
Files:.pdf PDF - Presentation file, download (1,58 MB)
MD5: 4EBE5330FD8D7C6D9BF42ABF96BBD7B9
 
URL URL - Source URL, visit https://www.mdpi.com/1422-0067/25/14/7674
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Determining the genetic contribution of susceptibility to severe SARS-CoV-2 infection outcomes is important for public health measures and individualized treatment. Through intense research on this topic, several hundred genes have been implicated as possibly contributing to the severe infection phenotype(s); however, the findings are complex and appear to be population- dependent. We aimed to determine the contribution of human rare genetic variants associated with a severe outcome of SARS-CoV-2 infections and their burden in the Slovenian population. A panel of 517 genes associated with severe SARS-CoV-2 infection were obtained by combining an extensive review of the literature, target genes identified by the COVID-19 Host Genetic Initiative, and the curated Research COVID-19 associated genes from PanelApp, England Genomics. Whole genome sequencing was performed using PCR-free WGS on DNA from 60 patients hospitalized due to severe COVID-19 disease, and the identified rare genomic variants were analyzed and classified according to the ACMG criteria. Background prevalence in the general Slovenian population was determined by comparison with sequencing data from 8025 individuals included in the Slovenian genomic database (SGDB). Results show that several rare pathogenic/likely pathogenic genomic variants in genes CFTR, MASP2, MEFV, TNFRSF13B, and RNASEL likely contribute to the severe infection outcomes in our patient cohort. These results represent an insight into the Slovenian genomic diversity associated with a severe COVID-19 outcome.
Keywords:severe COVID-19, severe outcome of SARS-CoV-2 infection, whole-genome sequencing, genetic susceptibility, rare variants, human rare genomic variants
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 1-16
Numbering:Vol. 25, iss. 14, [article no.] 7674
PID:20.500.12556/DiRROS-29989 New window
UDC:616.9
ISSN on article:1422-0067
DOI:10.3390/ijms25147674 New window
COBISS.SI-ID:204417283 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 15. 8. 2024;
Publication date in DiRROS:11.06.2026
Views:67
Downloads:49
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0326-2020
Name:Ginekologija in reprodukcija: Genomika za personalizirano medicino

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0360-2019
Name:Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back